The knowledge and technology transfer ceremony, hosted by SUNUM Director Prof. Dr. Alpagut Kara, was attended by Curium Nükleer Tıp A.Ş. Senior Vice President - Emerging Markets Aydın Küçük and his team, SUNUM Chair Cevdet Alemdar, Board Members, and SUNUM researchers.
Speaking at the signing ceremony, SUNUM Director Prof. Dr. Alpagut Kara said, “This project we are undertaking with Curium is a significant step in domestic technology production.” Kara stated that this agreement also demonstrates that SUNUM's technology transfer and R&D capabilities meet international standards and reflects the center's strong business development and commercialization culture. He emphasized that they will continue their advanced technology-focused work without slowing down. Curium Nükleer Tıp A.Ş. Senior Vice President - Emerging Markets Aydın Küçük said, “This collaboration is paving the way for the development of systems that play a critical role in cancer diagnosis in our country.”
The project, developed by SUNUM Lead Principal Investigator Assoc. Prof. Mustafa Kemal Bayazıt and to be transferred to Curium, involves making the processes from the scaled production of metal oxide particles, the column matrix, to the column filling stage operator-independent. These particles are placed in the columns of Germanium/Gallium generator devices used in cancer diagnosis, playing a key role in the radionuclide separation and transport processes.
The project carried out within the scope of the collaboration enables the domestic production of column material, a key component of a specialized system used in cancer diagnosis, enabling the safe and effective extraction of radioactive materials necessary for diagnosis, at a certain scale. The project outputs, achieved after approximately two years of intensive work by SUNUM researchers, are being transferred to Curium Nuclear Medicine Inc.
At SUNUM, we are pleased to make a strong contribution to Turkey's goals of localization in the fields of nuclear medicine and radiopharmaceuticals and to become a leader in the international market through this collaboration.
